Dog brain homogenates and subcellular preparations incubated in the presence of Ca2+ produced a new phospholipid that was isolated and identified by its infrared spectrum and by chemical degradation as a mixture of 1,2-diacyl, alkenylacyl, and alkylacyl sn-glycero-3-phospho(N-acyl)ethanolamines, 50, 45, and 5%, respectively. The N-acyl groups consisted almost exclusively of 16:0, 18:0, and 18:1 fatty acids. Formation of N-acylethanolamine phospholipids from endogenous substrates was linear for about 90 min at approximately 4.5 nmol/h/mg protein and exhibited a pH optimum of 10. Biosynthetic activity was associated with particulate fractions, primarily microsomes, synaptosomes, and mitochondria, but not with myelin. In each case, small amounts (approximately 0.5 nmol/h/mg protein) of long-chain N-acylethanolamines were also produced. Incubation of dog brain microsomes with 1,2-di[1'-14C]palmitoyl glycerophosphocholine yielded N-acylethanolamine phospholipids labeled at both N-acyl (55%) and O-acyl (45%) moieties. It appears that dog brain organelles may contain a phosphatidylethanolamine N-acyl transferase (transacylase) analogous to that recently demonstrated in the myocardial tissue.
No takes yet. Share an insight, caveat, or question.
Natarajan et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: